UNSPSC 51152011: Tubocurarine

This classification denotes a nicotinic antagonist and neuromuscular nondepolarizing agent with the molecular formula C37H41N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W9YXS298BM, chemically known as 13h-4,6:21,24-dietheno-8,12-metheno-1h-pyrido(3,2:14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,19-dihydroxy-18,29-dimethoxy-1,14,14-trimethyl-, (13ar,25as)- but generally known as tubocurarine, which bears US NIH Compound Identifier 6000.

UNSPSC 51152011 Tubocurarine is a Commodity code that in recent state and local procurement activity covers the purchase of naloxone and related drug-response products for public health deployment. State and local health departments and county community health agencies use this code to procure emergency medical supplies, particularly opioid antagonists and controlled-substance management systems, for community health initiatives and emergency response programs. The issuing bodies under this code include county health agencies and municipal health departments operating public health infrastructure.

Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement requires vendors to submit unit pricing electronically, maintain workers' compensation and commercial general liability insurance, achieve E-Verify compliance, and operate under a two-year initial term with a one-year renewal option. All shipping and delivery costs must be included in the bid. While recent state and local opportunities under this Commodity code are limited in the available record, Florida emerges as an active jurisdiction for naloxone and drug-response-system procurement.